Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858)

Shandong Buchang Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	958.28	694.13	2,149	1,218	1,470	1,829
Short-Term Investments	-	-	-	-	3.6	-
Trading Asset Securities	353.31	354.09	726.45	498.17	386.45	386.45
Cash & Short-Term Investments	1,312	1,048	2,875	1,716	1,860	2,216
Cash Growth	40.41%	-63.54%	67.56%	-7.73%	-16.07%	30.88%
Accounts Receivable	1,352	1,887	1,905	2,171	2,639	1,875
Other Receivables	132.21	152.16	164.69	200.57	324.83	654.35
Receivables	1,484	2,039	2,070	2,372	2,964	2,529
Inventory	4,467	4,930	3,789	3,834	2,767	1,925
Other Current Assets	286.62	263.32	257.42	430.37	395.99	351.23
Total Current Assets	7,550	8,281	8,991	8,352	7,986	7,022
Property, Plant & Equipment	5,900	6,000	6,301	5,919	5,343	4,725
Long-Term Investments	1,516	1,496	1,449	1,433	1,437	1,425
Goodwill	1,473	1,473	2,063	5,133	5,122	5,068
Other Intangible Assets	847.69	949.17	1,074	1,171	1,241	1,342
Long-Term Accounts Receivable	-	-	16.75	23.32	16.75	7.1
Long-Term Deferred Tax Assets	358.73	368.19	221.38	220.68	170.57	210.71
Long-Term Deferred Charges	1,592	1,386	1,125	978.44	870.21	642.96
Other Long-Term Assets	911.35	938.55	710.55	754.32	699.33	737.61
Total Assets	20,149	20,892	21,952	23,986	22,886	21,185
Accounts Payable	2,529	2,497	2,398	2,495	1,938	1,150
Accrued Expenses	96.87	2,286	2,318	1,903	2,023	1,499
Short-Term Debt	242.88	240.12	638.76	1,295	2,561	1,725
Current Portion of Long-Term Debt	794.22	737.93	307.04	307.42	68.9	180
Current Portion of Leases	-	64.32	53.69	14.96	-	-
Current Income Taxes Payable	154.16	83.29	95.54	118.67	136.94	124.18
Current Unearned Revenue	132.13	238	376.52	242.4	335.7	-
Other Current Liabilities	2,131	709.64	773.22	786.25	749.57	1,448
Total Current Liabilities	6,080	6,856	6,961	7,162	7,813	6,127
Long-Term Debt	2,784	2,098	2,127	1,902	824.32	813.4
Long-Term Leases	110.59	154.58	170.37	19.14	-	-
Long-Term Unearned Revenue	290.73	312.29	330.55	345.63	340.29	335.14
Long-Term Deferred Tax Liabilities	79.16	90.52	87.51	106.22	97.36	122.1
Other Long-Term Liabilities	0.96	5.07	-	-	-	-
Total Liabilities	9,345	9,516	9,677	9,536	9,075	7,397
Common Stock	1,106	1,106	1,106	1,142	1,142	1,142
Additional Paid-In Capital	2,493	2,493	2,494	3,392	3,385	3,385
Retained Earnings	8,185	8,008	8,751	10,806	10,122	10,046
Treasury Stock	-634.92	-1.85	-	-934	-934	-934
Comprehensive Income & Other	11.77	11.84	12.13	19.3	0.5	-0.08
Total Common Equity	11,161	11,617	12,363	14,425	13,715	13,638
Minority Interest	-357.71	-240.98	-87.58	25.17	96.19	149.73
Shareholders' Equity	10,803	11,376	12,275	14,450	13,811	13,788
Total Liabilities & Equity	20,149	20,892	21,952	23,986	22,886	21,185
Total Debt	3,931	3,295	3,297	3,539	3,455	2,718
Net Cash (Debt)	-2,620	-2,247	-421.83	-1,823	-1,595	-502.56
Net Cash Per Share	-2.39	-2.03	-0.38	-1.65	-1.44	-0.45
Filing Date Shares Outstanding	1,066	1,095	1,106	1,106	1,106	1,106
Total Common Shares Outstanding	1,066	1,106	1,106	1,106	1,106	1,106
Working Capital	1,470	1,425	2,030	1,190	172.57	895.26
Book Value Per Share	10.47	10.50	11.18	13.04	12.40	12.33
Tangible Book Value	8,840	9,195	9,225	8,121	7,351	7,229
Tangible Book Value Per Share	8.30	8.31	8.34	7.34	6.65	6.54
Buildings	-	5,036	5,195	3,211	2,455	1,922
Machinery	-	2,034	1,825	1,578	1,433	996.66
Construction In Progress	-	1,243	1,235	2,821	2,918	2,840

Source: S&P Capital IQ. Standard template. Financial Sources.